Synlogic (NASDAQ:SYBX) Stock Price Passes Below 50 Day Moving Average – What’s Next?

Synlogic, Inc. (NASDAQ:SYBX) crossed below its 50-day moving average during trading on Wednesday . The stock has a 50-day moving average of $1.35 and traded as low as $1.27. Synlogic shares last traded at $1.31, with a volume of 1,037 shares traded.

Synlogic Stock Up 0.8 %

The company has a market cap of $15.31 million, a PE ratio of -0.31 and a beta of 0.72. The firm has a 50 day simple moving average of $1.35 and a 200-day simple moving average of $1.41.

Synlogic (NASDAQ:SYBX) last posted its quarterly earnings data on Thursday, March 6th. The biotechnology company reported ($0.06) EPS for the quarter, topping the consensus estimate of ($0.10) by $0.04. As a group, equities analysts anticipate that Synlogic, Inc. will post -2.71 EPS for the current year.

Synlogic Company Profile

Synlogic, Inc, a clinical-stage biopharmaceutical company, engages in the discovery and development of synthetic biotics to treat metabolic diseases in the United States. Its pipeline include SYNB1618, an orally administered, non-systemically absorbed drug candidate to treat phenylketonuria; SYNB1934, an orally administered, non-systemically absorbed drug candidate, which is in Phase III clinical trial to treat phenylketonuria; SYNB1353, an orally administered, non-systemically absorbed drug candidate, which is in Phase I clinical to treat homocystinuria; SYNB8802, an orally administered, non-systemically absorbed drug candidate that is in Phase II clinical trial for the treatment of enteric hyperoxaluria; and SYNB2081 to lower uric acid for the potential treatment of gout.